To design an effective HIV vaccine, Mass General researcher Todd Allen, PhD, is focused on understanding how HIV evades the body’s immune system defenses.
Hunting the causes of brain degeneration is leading neuroscientists to exciting new possible therapies to help patients with Parkinson’s disease and ALS.
A young researcher at Mass General is exploring ways to diagnose and track multiple sclerosis more accurately with stronger and faster imaging technologies.
In her Mass General lab, Ghazaleh Sadri-Vakili, PhD, aims to identify the underlying molecular mechanisms of Huntington’s disease and ALS.
Mass General research is helping children and adults with neurofibromatosis lead a full life.
The FDA recently sponsored a milestone meeting aimed at pursuing alternative treatments for celiac patients who do not respond well to a gluten-free diet.
When the late Paul Poth was diagnosed with a form of cancer so rare there was no treatment, he helped to launch a highly promising area of cancer research that is giving new hope to patients.
Running to train for a marathon cuts heart disease risk and boosts heart structure and function, according to a study led by cardiologist Aaron Baggish, MD.
Mass General researcher and donor Joel Habener, MD, advances diabetes research and the careers of promising young investigators.
The scientists at the Massachusetts Alzheimer’s Disease Research Center are pioneering a unique new gene therapy that could stop the disease in its tracks.